BMP4, PHLDA1, and GJB expression levels in pairs of tumors and adjacent normal tissues from the patients with CRC obtained using GEP were significantly higher (P < 0.001) in the KRAS G12 mutant compared with those in the wild-type (Fig. 6a). This evidence concerns the gene PHLDA1 and colorectal carcinoma.